CYCLERION THERAPEUTICS INC - COMMON STOCK (CYCN)
CUSIP: 23255M105
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 4,330,313
- Total 13F shares
- 20,901,901
- Share change
- -2,054,682
- Total reported value
- $11,469,174
- Price per share
- $0.55
- Number of holders
- 32
- Value change
- -$2,261,052
- Number of buys
- 10
- Number of sells
- 22
Quarterly Holders Quick Answers
What is CUSIP 23255M105?
CUSIP 23255M105 identifies CYCN - CYCLERION THERAPEUTICS INC - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 23255M105:
Top shareholders of CYCN - CYCLERION THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Slate Path Capital LP |
13F
|
Company |
165%
|
7,157,601
|
$7,945,000 | — | 31 Mar 2022 | |
| MFN Partners Management, LP |
13F
|
Company |
78%
|
3,389,215
|
$3,762,000 | — | 31 Mar 2022 | |
| Artal Group S.A. |
13F
|
Company |
64%
|
2,779,122
|
$3,085,000 | — | 31 Mar 2022 | |
| FMR LLC |
13F
|
Company |
60%
|
2,615,007
|
$2,903,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
41%
|
1,754,153
|
$1,947,000 | — | 31 Mar 2022 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
18%
|
776,497
|
$862,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
13%
|
583,383
|
$647,000 | — | 31 Mar 2022 | |
| Ikarian Capital, LLC |
13F
|
Company |
12%
|
527,462
|
$585,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
10%
|
441,364
|
$490,000 | — | 31 Mar 2022 | |
| Eversept Partners, LP |
13F
|
Company |
8.6%
|
371,955
|
$412,870 | — | 31 Mar 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
7%
|
302,558
|
$336,000 | — | 31 Mar 2022 | |
| TRUSTCORE FINANCIAL SERVICES, LLC |
13F
|
Company |
6.8%
|
292,645
|
$325,000 | — | 31 Mar 2022 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
5.4%
|
231,952
|
$256,000 | — | 31 Mar 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
5%
|
215,100
|
$239,000 | — | 31 Mar 2022 | |
| Diametric Capital, LP |
13F
|
Company |
4.2%
|
182,930
|
$203,000 | — | 31 Mar 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
3.6%
|
155,206
|
$172,000 | — | 31 Mar 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
2.8%
|
122,249
|
$136,000 | — | 31 Mar 2022 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
2.7%
|
115,642
|
$128,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
2.7%
|
115,549
|
$128,000 | — | 31 Mar 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.7%
|
115,000
|
$128,000 | — | 31 Mar 2022 | |
| COLONY GROUP LLC |
13F
|
Company |
2.4%
|
102,884
|
$114,000 | — | 31 Mar 2022 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
100,255
|
$111,000 | — | 31 Mar 2022 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
2.2%
|
94,126
|
$104,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.9%
|
80,736
|
$90,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.5%
|
66,512
|
$74,000 | — | 31 Mar 2022 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
50,761
|
$56,000 | — | 31 Mar 2022 | |
| Intrinsic Value Partners, LLC |
13F
|
Company |
1.2%
|
49,915
|
$55,000 | — | 31 Mar 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1%
|
45,058
|
$50,000 | — | 31 Mar 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.98%
|
42,400
|
$47,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.9%
|
38,992
|
$43,000 | — | 31 Mar 2022 | |
| MACKENZIE FINANCIAL CORP |
13F
|
Company |
0.58%
|
25,309
|
$28,000 | — | 31 Mar 2022 | |
| Verition Fund Management LLC |
13F
|
Company |
0.46%
|
20,000
|
$22,000 | — | 31 Mar 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.46%
|
19,832
|
$22,000 | — | 31 Mar 2022 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.42%
|
18,268
|
$20,000 | — | 31 Mar 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.4%
|
17,460
|
$19,000 | — | 31 Mar 2022 | |
| DAVENPORT & Co LLC |
13F
|
Company |
0.3%
|
13,000
|
$14,000 | — | 31 Mar 2022 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.23%
|
10,149
|
$11,265 | — | 31 Mar 2022 | |
| Sawyer & Company, Inc |
13F
|
Company |
0.09%
|
4,100
|
$5,000 | — | 31 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0.08%
|
3,645
|
$4,000 | — | 31 Mar 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.06%
|
2,400
|
$3,000 | — | 31 Mar 2022 | |
| High Net Worth Advisory Group LLC |
13F
|
Company |
0.02%
|
1,000
|
$1,000 | — | 31 Mar 2022 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.01%
|
287
|
$319 | — | 31 Mar 2022 | |
| Andreas Busch |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
135,000
|
— | — | 20 Jan 2022 | |
| Anjeza Gjino |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
135,000
|
— | — | 20 Jan 2022 | |
| Cheryl Gault |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
135,000
|
— | — | 20 Jan 2022 | |
| George H. Conrades |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 14 Jun 2022 | |
| Marsha Fanucci |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 14 Jun 2022 | |
| Michael Mendelsohn |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 14 Jun 2022 | |
| Ole Isacson |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 14 Jun 2022 | |
| Stephanie Lovell |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 14 Jun 2022 |
Institutional Holders of CYCLERION THERAPEUTICS INC - COMMON STOCK (CYCN) as of Q2 2022
As of 30 Jun 2022,
CYCLERION THERAPEUTICS INC - COMMON STOCK (CYCN) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,901,901 shares.
The largest 10 holders included
Slate Path Capital LP, MFN Partners Management, LP, Artal Group S.A., FMR LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., TRUSTCORE FINANCIAL SERVICES, LLC, and Diametric Capital, LP.
This page lists
32
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
42
Q2 2022 holders
32
Holder diff
-10
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.